Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex confirms plans to make Belgrade the main European hub

6/16/23 YNDX

JFSC Sistema will continue to pay dividends at the level of previous years

6/15/23 AFKS

Moscow Exchange has launched an analogue of Bloomberg terminal

6/15/23 MOEX

The Delta Air Lines announced a quarterly dividend

6/15/23 DAL

Rostelecom and NMG signed an agreement to merge the Wink and More.tv video services

6/15/23 RTKM

Rusal will build an alumina refinery in the Leningrad region with a capacity of 4.8 million tons

6/15/23 RUAL

Trust sold 3.61% of Russneft's common shares

6/15/23 RNFT

Chizhik opened the first stores in the Saratov region

6/15/23 FIVE

Sistema's OIBDA in Q1 2023 increased by 12.9%

6/15/23 AFKS

The Caterpillar announced a quarterly dividend

6/15/23 CAT